On ECHEMI
Home > Drugs > Cycloamycin Capsules

Cycloamycin Capsules

Function and Efficacy

The structure is similar to that of papaverine. Single or continuous administration can increase blood flow to the brain, heart, kidneys and limbs. It can directly relax vascular smooth muscle to dilate blood vessels, and has a selective and sustained dilation effect on the brain, kidneys, blood vessels and coronary arteries, thereby increasing blood flow. The effect is weaker and more lasting than that of papaverine. This product can also promote collateral circulation. It has almost no effect on respiration, heart rate, cardiac output, myocardial oxygen consumption, blood pressure, etc.

Ingredients

The main ingredient and chemical name of this product are: 3,3,5-trimethylcycloethanol-α-phenyl-α-hydroxyacetate

Appearance

This product is a capsule, the contents are white or off-white amorphous powder

Indication

It is used for ischemic cerebrovascular disease, cerebral arteriosclerosis, sequelae of brain trauma, acral artery spasm, acrocyanosis, occlusive endarteritis, inner ear vertigo, etc.

Usage and Dosage

800-1200 mg/day. 100-200 mg each time, 3-4 times a day. After the symptoms improve, the dosage can be reduced to 300-400 mg a day. For cerebrovascular diseases, generally take 200-400 mg each time, 3 times a day.

Adverse Reactions

It can cause nausea, vomiting, loss of appetite, upper abdominal discomfort, and sometimes facial flushing, dizziness, headache, rash, pruritus, dry mouth, palpitations, hypotension, numbness, tremor, tachycardia, sweating, etc.

Precautions

It is contraindicated for use in patients in the acute stage of severe cerebrovascular accident, pregnant women, and lactating women.

Special Population Medication

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Drug Interactions

Not yet clear.

Storage

Keep in dark place and sealed

Packaging Specification

0.1g

Validity Period

24 months

Manufacturer

Shanxi Shuangyan Pharmaceutical Co., Ltd.

  • Founded in:

    2004-06-18
  • Address:

    Datong Development Zone Pharmaceutical Industrial Park
  • Tax NO.:

    91140200762481795D
  • Registered Funds:

    250 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.